Thymomas (Ts) and thymic carcinomas (TCs) are rare tumours of the mediastinum with an
incidence rate of 1.7/million per year in Europe. Histological classification is based on rate of …

Thymomas are further subdivided into different types (called A, AB, B1, B2, B3 and rare
others) based upon the morphology of epithelial tumour cells, the relative proportion of the …

In this review article, state-of-the-art diagnostic tools and innovative treatments of thymoma
and thymic carcinoma (TC) are described with special respect to advanced tumour stages …

OBJECTIVES Thymic carcinoma is a rare thymic malignancy. The purpose of this study was
to evaluate the prognostic impact of clinicopathological variables and perioperative therapy …

Objective Primary neuroendocrine tumors of the thymus (TNET) are exceedingly rare. We
studied a large series of TNET identified through the International Thymic Malignancy …

Aim To perform a systematic review and meta-analysis of published data on the role of
fluorine-18-fluorodeoxyglucose positron emission tomography (18 F-FDG PET) in predicting …

OBJECTIVE. The purpose of this study was to evaluate the diagnostic yield and accuracy of
CT-guided percutaneous biopsy of anterior mediastinal masses and assess prebiopsy …

Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for
less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly …

Background To investigate the clinical characteristics and therapeutic outcomes of patients
who underwent surgery for stage III thymoma in Japan. Methods Using the Japanese …

Thymic epithelial tumors (TETs) are a heterogenous group of rare tumors, with a complex
histopatological classification. Furthermore, the recent introduction of the first TNM staging …